Literature DB >> 11553569

Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp.

A Al-Mariri1, A Tibor, P Mertens, X De Bolle, P Michel, J Godfroid, K Walravens, J J Letesson.   

Abstract

In this study, we evaluated the ability of DNA vaccines encoding the bacterioferritin (BFR) or P39 proteins of Brucella spp. to induce cellular and humoral immune responses and to protect BALB/c mice against a challenge with B. abortus 544. We constructed eukaryotic expression vectors called pCIBFR and pCIP39, encoding BFR or P39 antigens, respectively, and we verified that these proteins were produced after transfection of COS-7 cells. PCIBFR or pCIP39 was injected intramuscularly three times, at 3-week intervals. pCIP39 induced higher antibody responses than did the DNA vector encoding BFR. Both vectors elicited a T-cell-proliferative response and also induced a strong gamma interferon production upon restimulation with either the specific antigens or Brucella extract. In this report, we also demonstrate that animals immunized with these plasmids elicited a strong and long-lived memory immune response which persisted at least 3 months after the third vaccination. Furthermore, pCIBFR and pCIP39 induced a typical T-helper 1-dominated immune response in mice, as determined by cytokine or immunoglobulin G isotype analysis. The pCIP39 delivered by intramuscular injection (but not the pCIBFR or control vectors) induced a moderate protection in BALB/c mice challenged with B. abortus 544 compared to that observed in positive control mice vaccinated with S19.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553569      PMCID: PMC98760          DOI: 10.1128/IAI.69.10.6264-6270.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  61 in total

Review 1.  Immune recognition of foreign DNA: a cure for bioterrorism?

Authors:  D M Klinman; D Verthelyi; F Takeshita; K J Ishii
Journal:  Immunity       Date:  1999-08       Impact factor: 31.745

2.  Vaccination against bovine brucellosis with a low dose of strain 19 administered by the conjunctival route. IV. Comparison between two methods of vaccination.

Authors:  R Fensterbank; M Plommet
Journal:  Ann Rech Vet       Date:  1979

Review 3.  Pathogenesis of Brucella.

Authors:  L D Smith; T A Ficht
Journal:  Crit Rev Microbiol       Date:  1990       Impact factor: 7.624

4.  Characterization of a monoclonal antibody specific for Brucella smooth lipopolysaccharide and development of a competitive enzyme-linked immunosorbent assay to improve the serological diagnosis of brucellosis.

Authors:  V Weynants; D Gilson; A Cloeckaert; P A Denoel; A Tibor; P Thiange; J N Limet; J J Letesson
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

Review 5.  CD4+ T cells: specificity and function.

Authors:  C A Janeway; S Carding; B Jones; J Murray; P Portoles; R Rasmussen; J Rojo; K Saizawa; J West; K Bottomly
Journal:  Immunol Rev       Date:  1988-01       Impact factor: 12.988

6.  Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.

Authors:  A Tanghe; S D'Souza; V Rosseels; O Denis; T H Ottenhoff; W Dalemans; C Wheeler; K Huygen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.

Authors:  L N Araya; P H Elzer; G E Rowe; F M Enright; A J Winter
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

8.  Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages.

Authors:  S M Jones; A J Winter
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

9.  Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.

Authors:  A Al-Mariri; A Tibor; P Mertens; X De Bolle; P Michel; J Godefroid; K Walravens; J J Letesson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

10.  Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice.

Authors:  M G Stevens; G W Pugh; L B Tabatabai
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

View more
  19 in total

1.  Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice.

Authors:  Deyan Luo; Bing Ni; Peng Li; Wei Shi; Songle Zhang; Yue Han; Liwei Mao; Yangdong He; Yuzhang Wu; Xiliang Wang
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Intradermal active full-length DNA Aβ42 immunization via electroporation leads to high anti-Aβ antibody levels in wild-type mice.

Authors:  Roger N Rosenberg; Min Fu; Doris Lambracht-Washington
Journal:  J Neuroimmunol       Date:  2018-06-11       Impact factor: 3.478

3.  A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.

Authors:  Juliana Cassataro; Carlos A Velikovsky; Silvia de la Barrera; Silvia M Estein; Laura Bruno; Raúl Bowden; Karina A Pasquevich; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Construction of an expression plasmid (vector) encoding Brucella melitensis outer membrane protein, a candidate for DNA vaccine.

Authors:  Fatemeh Vahedi; Elnaz Ghorbani; Tahereh Falsafi
Journal:  Rep Biochem Mol Biol       Date:  2013-04

5.  An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Angel A Oñate; Gabriel Donoso; Gustavo Moraga-Cid; Hugo Folch; Sandra Céspedes; Edilia Andrews
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs.

Authors:  Cora N Pollak; María Magdalena Wanke; Silvia M Estein; M Victoria Delpino; Norma E Monachesi; Elida A Comercio; Carlos A Fossati; Pablo C Baldi
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

7.  Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.

Authors:  Anne G Savitt; Patricio Mena-Taboada; Gloria Monsalve; Jorge L Benach
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

8.  A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Angel A Oñate; Sandra Céspedes; Alex Cabrera; Rodolfo Rivers; Andrés González; Carola Muñoz; Hugo Folch; Edilia Andrews
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used.

Authors:  Carlos A Velikovsky; Fernando A Goldbaum; Juliana Cassataro; Silvia Estein; Raúl A Bowden; Laura Bruno; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells.

Authors:  Carola Muñoz-Montesino; Edilia Andrews; Rodolfo Rivers; Andrés González-Smith; Gustavo Moraga-Cid; Hugo Folch; Sandra Céspedes; Angel A Oñate
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.